Core‐Shell Reactor Partitioning Enzyme and Prodrug by ZIF‐8 for NADPH‐Sensitive In Situ Prodrug Activation
Authors:
- 9 November 2023
- journal article
- research article
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 62 (50) , e202314025
Abstract
Enzyme‐prodrug therapies have shown unique advantages in efficiency, selectivity, and specificity of in vivo prodrug activation. However, precise spatiotemporal control of both the enzyme and its substrate at the target site, preservation of enzyme activity, and in situ substrate depletion due to low prodrug delivery efficiency continue to be great challenges. Here, we propose a novel core–shell reactor partitioning enzyme and prodrug by ZIF‐8, which integrates an enzyme with its substrate and increases the drug loading capacity (DLC) using a prodrug as the building ligand to form a Zn‐prodrug shell. Cytochrome P450 (CYP450) is immobilized in ZIF‐8, and the antitumor drug dacarbazine (DTIC) is coordinated and deposited in its outer layer with a high DLC of 43.6±0.8 %. With this configuration, a much higher prodrug conversion efficiency of CYP450 (36.5±1.5 %) and lower IC50 value (26.3±2.6 μg/mL) are measured for B16‐F10 cells with a higher NADPH concentration than those of L02 cells and HUVECs. With the tumor targeting ability of hyaluronic acid, this core–shell enzyme reactor shows a high tumor suppression rate of 96.6±1.9 % and provides a simple and versatile strategy for enabling in vivo biocatalysis to be more efficient, selective, and safer.Keywords
Funding Information
- National Natural Science Foundation of China (31870946, 32271453)
This publication has 55 references indexed in Scilit:
- Rapid synthesis of zeolitic imidazolate framework-8 (ZIF-8) nanocrystals in an aqueous systemChemical Communications, 2011
- Cyclophosphamide and cancer: golden anniversaryNature Reviews Clinical Oncology, 2009
- Understanding the Warburg Effect: The Metabolic Requirements of Cell ProliferationScience, 2009
- Imidazole groups on a linear, cyclodextrin-containing polycation produce enhanced gene delivery via multiple processesJournal of Controlled Release, 2006
- Hepatotoxicity of ChemotherapySeminars in Oncology, 2006
- Enzyme-Catalyzed Activation of Anticancer ProdrugsPharmacological Reviews, 2004
- Inhibition and induction of human cytochrome P450 (CYP) enzymesXenobiotica, 1998
- Metabolic activation of toxins: tissue-specific expression and metabolism in target organs.Environmental Health Perspectives, 1997
- The crystal structure of the anti-tumor agent 5-(3,3-dimethyl-1-triazenyl)imidazole-4-carboxamide (NSC-45388)Acta crystallographica Section B, Structural science, crystal engineering and materials, 1979
- Methylation of nucleic acids and urinary excretion of 14C-labeled 7-methylguanine by rats and man after administration of 4(5)-(3,3-Dimethyl-1-triazeno)-imidazole 5(4)-carboxomideToxicology and Applied Pharmacology, 1971